Aggrecan heterogeneity in articular cartilage from patients with osteoarthritis

Table 2 Proportions of aggrecanase and MMP G1 degradation products

Patient ID	Aggrecanase G1^a	MMP G1^a	Ratio (G1-Agg/G1-MMP)
3	338	290	1.16
4	579	223	2.59
5	251	302	0.83
6	388	165	2.35
7	516	335	1.54
8	456	156	2.92
9	352	352	1.00
10	671	423	1.58
11	904	574	1.57
12	396	139	2.84
13	643	171	3.76
14	226	59.9	3.77
15	263	116	2.26
16	491	190	2.58
17	524	392	1.34
18	503	110	4.57
19	23.2	111	0.21
20	515	200	2.57
21	386	306	1.26
22	452	271	1.66
23	240	177	1.36
24	518	259	2.00
25	218	10.8	20.2
26	323	45.4	7.12
27	405	480	0.84
28	256	280	0.91
29	324	273	1.18
30	726	604	1.20
31	215	96.6	2.23
32	254	243	1.04
33	418	213	1.96
34	56.0	27.2	2.06

ISSN: 1471-2474